MedPath

Epithelial Mesenchymal Transition and Periodontitis

Conditions
Periodontal Diseases
Epithelial-Mesenchymal Transition
Periodontitis
Transcription Factors
Epithelial Attachment
Gram-Negative Bacteria
Interventions
Procedure: Modified Widman flap
Procedure: Gingivectomy
Registration Number
NCT05403164
Lead Sponsor
University of Baghdad
Brief Summary

Periodontitis is a chronic inflammatory disease results is destruction of the attachment apparatus of the teeth and ultimately tooth loss.

Epithelial-mesenchymal transition (EMT) is a process comprises of series of events that influence a polarized epithelial cell to undergo molecular/morphological changes leading to acquisition of mesenchymal cell phenotype. This process is responsible for suppressing epithelial-phenotype and it is known to be triggered by chronic exposure to inflammatory cytokines, Gram-negative bacteria, hypoxia, smoking, and hyperglycemia.

Both periodontitis and EMT share common risk factors/promoters; however, the role of EMT in the pathogenesis of periodontitis is not fully elucidated yet. Potential induction of EMT within periodontal pockets may disrupt epithelial barrier thus facilitating invasion of pathogenic periodontal pathogens to deeper tissues resulting in further tissue breakdown and non-resolving periodontal lesion.

Detailed Description

Periodontitis is a highly prevalent inflammatory disease affecting the attachment apparatus of the teeth, leading to progressive destruction of periodontal ligament and resorption of alveolar bone which if not treated, at early stages, it will lead to tooth loss. It is characterised by presence of a wide diversity of pathogenic bacteria, specifically Gram-negative anaerobes, that possess range of virulence factors responsible for triggering intense inflammatory response. Although this response is protective in nature; however, it leads to undesirable collateral damage to the surrounding tissues that is further aggravated by the aberrant immune response of the host.

Epithelial-mesenchymal transition (EMT) is a process comprises of series of events that influence a polarized epithelial cell to undergo molecular/morphological changes leading to acquisition of mesenchymal cell phenotype. EMT is modulated by range of regulatory pathways; mainly, downstream of TGF-β signaling activity which is evident in many developmental and pathological situations in which EMT is reported, including embryogenesis, inflammation and tumor metastasis. The hallmark of TGFβ signaling is up-regulation of Snail, an E-cadherin repressor. Overexpression of Snail has been found in various fibrotic diseases, including liver fibrosis and renal fibrosis.

E-cadherin is a calcium-dependent homophilic cell adhesion molecule expressed on the cell surfaces of epithelium and is a critical structure for stratification of squamous epithelia. The significant reduction in E-cadherin expression observed in the gingival epithelium during pocket formation and is believed to contribute to the pathogenesis of periodontal disease.

Vimentin is a type III intermediate filament (IF) protein that is expressed in mesenchymal cells. IF, along with tubulin-based microtubules and actin-based microfilaments, comprises the cytoskeleton. All IF proteins are expressed in a highly developmentally-regulated fashion; vimentin is the major cytoskeletal component of mesenchymal cells. Because of this, vimentin is often used as a marker of mesenchymal-derived cells or cells undergoing EMT during both normal development and metastatic progression.

β-catenin is a dual function protein, involved in regulation and coordination of cell-cell adhesion and gene transcription. β-catenin also acts as a morphogen in later stages of embryonic development. Together with TGF-β, an important role of β-catenin is to induce a morphogenic change in epithelial cells. It induces them to abandon their tight adhesion and assume a more mobile and loosely associated mesenchymal phenotype.

Role of EMT on compromising epithelial barrier function of periodontal pocket lining is not fully elucidated yet. Reported risk factors of EMT including prolonged exposure to cytokines, Gram-negative bacteria, tobacco and hypoxia are also relevant to periodontitis. Potential induction of EMT within periodontal pockets may disrupt epithelial barrier thus facilitating invasion of pathogenic periodontal pathogens to deeper tissues resulting in further tissue breakdown and non-resolving periodontal lesion.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Diagnosed with generalized periodontitis, unstable, no risk factor
  • Selected site should be indicated for surgical treatment by modified Widman flap in posterior area and these sites must exhibit periodontal pockets ≥ 5mm or pockets ≥ 4mm with BOP
  • Plaque index score < 10%
  • Never smoker or former smoker
  • Not currently using systemic or local antimicrobials (at least in the last three months)
  • Not currently using a mouth rinse
  • In good general health with no evidence of any systemic disease
  • Willing to consent
Exclusion Criteria
  • Have history of systemic disease e.g., diabetes mellitus
  • Periodontal treatment in the last 6 months
  • Current participation in other clinical trials
  • Pregnant women
  • Current smoker
  • Not willing to sign the consent form

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
PeriodontitisModified Widman flapPatients with periodontitis which is defined by interdental clinical attachment loss (CAL) ≥ 2 non-adjacent teeth, or Buccal or Oral CAL ≥ 3 mm with probing pocket depth (PPD) \> 3 mm is detectable at ≥2 teeth. All patients should be indicated for periodontal surgery.
Healthy periodontiumGingivectomyHealthy periodontium is defined by absence of CAL, PPD ≤3 mm, bleeding on probing \<10%, and no evidence of radiological bone loss. Gingival samples are collected from subjects referred for gingivectomy for esthetic reasons such as crown lengthening, gummy smile or prior to teeth extraction for orthodontic treatment.
Primary Outcome Measures
NameTimeMethod
Probing pocket depth (PPD)Measured at baseline only before conducting periodontal surgery

PPD is the distance (in mm) from the gingival margin to the base of the sulcus/periodontal pocket measured by using a periodontal probe, recorded at six sites per tooth namely; mesio-facial, mid-facial, disto-facial, mesio-oral, mid-oral, disto-oral.

Clinical attachment loss (CAL)Measured at baseline only before conducting periodontal surgery

CAL is a linear distance (in mm) from cemento-enamel junction to the base of the sulcus/periodontal pocket measured by using a periodontal probe, recorded at six sites per tooth namely; mesio-facial, mid-facial, disto-facial, mesio-oral, mid-oral, disto-oral.

Secondary Outcome Measures
NameTimeMethod
Immunohistochemical expression of EMT-related markersMeasured at baseline

Immunohistochemical expressions of four EMT-related markers (E-cadherin, Snail1, vimentin, β-catenin) in gingival samples collected from patients with periodontitis and healthy periodontium are measured.

Bleeding on probing (BOP)Measured at baseline only before conducting periodontal surgery

BOP is measured by inserting a periodontal probe to the bottom of the gingival sulcus/periodontal pocket and moved gently along the tooth (root) surface. If bleeding occurs within 30 seconds after probing, the site is given score (1), and a negative score (0) for the non-bleeding site. BOP is recorded at six sites per tooth namely; mesio-facial, mid-facial, disto-facial, mesio-oral, mid-oral, disto-oral.

Trial Locations

Locations (1)

College of Dentistry, University of Baghdad

🇮🇶

Baghdad, Iraq

© Copyright 2025. All Rights Reserved by MedPath